Dr. Paul Bertics, Professor
Joined ERP Program: 1988

Department: Biomolecular Chemistry; Faculty Profile
Mailing Address: 571A Medical Sciences Center, 1215 Linden Dr., Madison, WI 53706
Telephone: (608) 262-8667  FAX: (608) 262-5253
Email: pbertics@wisc.edu

Biographical Information:

Institution Degree  Date Area of Study
University of CA- Los Angles B.S. 1978 Biochemistry
UW-Madison Ph.D. 1984 Physiological Chemistry
University of CA- San Diego Postdoc 1984-86 Cell & Molecular Biology

Professional Experience:

8/86-6/96 Assistant, Associate Prof, Dept. of Biomolecular Chem, Univ. of Wisconsin, Madison, WI 
7/96-present ProfessorDept. of Biomolecular Chem., Univ. of Wisconsin, Madison, WI
7/99-present  Chair, Univ. of Wisconsin Medical School Admissions
7/96-present Chair, Univ. of Wisconsin Medical School Research Committee
6/88-present  Member, Endocrinology-Reproductive Physiology Program, Univ. of Wisconsin, Madison, WI
8/89-present Member, Univ. of Wisconsin Comprehensive Cancer Center
8/88-present  Associate Member, Univ. of Wisconsin Clinical Cancer Center, Madison, WI
8/87-present Member, Cellular &   Molecular Biology Program, Univ. of Wisconsin, Madison, WI
2002-present

Cell Signaling Program Leader, UW Comprehensive Cancer Center, UW-Madison

Honors and Awards:

  • University of Wisconsin Medical School Distinguished Teaching Award (2000)
  • Hilldale Undergraduate/Faculty Research Fellowship Award - Univ. of Wisconsin (1991, 1993-2000)
  • University of Wisconsin Distinguished Teaching Award-Chancellor's Teaching Award (1997)
  • University of Wisconsin Medical School Deans Outstanding Teacher Award (1992)
  • Eli Lilly Biochemistry Award (1990)
  • Dorothy and Charles Inbusch Award for Meritorious Research (1990)
  • March of Dimes Basic O’Connor Starter Scholar Research Award (1987)
  • Shaw Scholar Award (Milwaukee Foundation) (1987)
  • Univ. of California, Los Angeles, Magna cum laude and ‘Highest Honors in Biochemistry (1978)
  • The Kellett Mid-Career Professorship Award for Outstanding Research (2006)  

Research Statement:

The research program is focused on characterizing the regulation of cell proliferation and function by growth factors, cytokines and bacterial toxins (i.e., endotoxin). Accordingly, this work has direct application to the understanding of the events that are involved in the development of cancer and the mechanisms associated with the immune response that is generated following bacterial infections. The growth factor research has centered on an examination of the structure, regulation and mode of action of the epidermal growth factor (EGF) receptor, which is a ligand-activated protein-tyrosine kinase known to be of considerable importance in cell growth control. These studies also entail an analysis of systems that can serve to regulate EGF receptor function, includ ing protein kinase C and growth hormone receptor-mediated pathways. Because abnormal control of the EGF receptor can lead to metastatic cqancer, we have a special interest in the role of the EGF receptor as an anti-cancer target. In particular, our studies have focused on examining how EGF receptor kinase activity can be specified/modulated by direct receptor association with the cellular cytoskeleton, membrane lipid rafts, the extracellular matrix (ECM), and ECM receptors.

In terms of our studies on immune function, our work has centered on analyzing the regulation of two types of leukocytes (white blood cells), namely the macrophage and the eosinophil. Our studies have revealed that the action of nucleotide receptors (ATP/ADP receptors), which are often activated following tissue damage, inflammation and clotting, appear critical for bacterial endotoxin to bring about its biological effects such as macrophage activation, cytokine production, shock and death. Similarly, the function of receptors for the interleukin-5 (IL-5) family of cytokines is essential for eosinophil activation and inflammatory responses associated with the development of diseases such as asthma. Therefore, we are currently assessing the signaling mechanisms associated with endotoxin, IL-5 and nucleotide-mediated immunomodulation, with an emphasis on the structural and functional characterization of the capacity of selected adenine nucleotides to protect animals from endotoxic death.

Current Grant Funding:

Funding Period Project
09/01/05-09/01/10

PI: de Pablo
NSF DMR-0520527
Materials Research Science and Engineering Center on Nanostructured Materials and Interface

09/01/00 - 09/01-10 PI: Bertics
NSF - DMR 0079983
Biophotonics Partnership Initiative- Nanodection of Biomolecules
09/01/05 - 09/30/10 PI: Bertics
NSF - DMR0520527
Materials Research Science and Engineering Center (MRSCE)
07/01/06 - 06/30/11 WARF - Kellett Mid-Career Faculty Research Award
07/01/06 - 06/30/11 PI: Bertics
NIH/NIAID 1 U19A1070503
Mechanisms of Rhinovirus-Induced Exacerbations of Asthma
08/01/06 - 07/31/11

PI: Bertics
NIH 2 R01HL069116-06
Severe Asthma from Respiratory Infections

06/01/07 - 05/31/10 PI: Bertics
NIH/NCI
Molecular Analysis Using Liquid Crystal Technology

Former ERP Program Trainees:

  • Linda Winston, Ph.D., 12/91
    Dissertation: "A role for protein-tyrosine phosphorylation in growth hormone signal transduction"
    PubMed Citations

  • Ann Gronowski, Ph.D., 12/92
    Dissertation:"Interaction of the epidermal growth factor receptor with the cellular cytoskeleton"
    PubMed Citations

  • Yong-Nyun Kim, Ph.D., 12/99
    Dissertation: "Epidermal growth factor-dependent tyrosine phosphorylation of caveolin-1"
    PubMed Citations

  • Benjamin Woods, M.S., 12/04
    MS Thesis: "Alterations in cellular cholesterol affect EGF receptor-associated signaling"
    PubMed Citation

  • Nichole Korpi-Steiner, Ph.D., 12/06
    Dissertation: "Mechanisms of cytokine elaboration by human alveolar macrophages and bronchial epithelial cells following rhinovirus challenge"
    PubMed Citations

Publications from Dr. Bertics' Lab Search Pub Med